Kevin Pollack
2016
In 2016, Kevin Pollack earned a total compensation of $4.7M as CFO at OPIANT PHARMACEUTICALS, a 257% increase compared to previous year.
Compensation breakdown
| Bonus | $530,000 |
|---|---|
| Option Awards | $3,500,000 |
| Salary | $610,333 |
| Other | $27,358 |
| Total | $4,667,691 |
Pollack received $3.5M in option awards, accounting for 75% of the total pay in 2016.
Pollack also received $530K in bonus, $610.3K in salary and $27.4K in other compensation.
Rankings
In 2016, Kevin Pollack's compensation ranked 1,786th out of 14,075 executives tracked by ExecPay. In other words, Pollack earned more than 87.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,786 out of 14,075 | 87th |
Division Mining | 92 out of 597 | 85th |
Major group Metal Mining | 9 out of 77 | 88th |
Source: SEC filing on July 27, 2017.
Pollack's colleagues
We found two more compensation records of executives who worked with Kevin Pollack at OPIANT PHARMACEUTICALS in 2016.